コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ndependent of protein expression within live macrophage cells.
2 in vitro BBB model and suppress the HIV-1 in macrophage cells.
3 suppresses production of bactericidal NO in macrophage cells.
4 fect the viral replication in swine alveolar macrophage cells.
5 ore as a fluorescent probe on the example of macrophage cells.
6 etion of mature IL-1beta (m-IL-1beta) in non-macrophage cells.
7 adhesive interactions between erythroid and macrophage cells.
8 gulation of necroptosis by cathepsins within macrophage cells.
9 glutathione-conjugated metabolite), against macrophage cells.
10 illumination microscopy (SIM) in J774 mouse macrophage cells.
11 ity index (SI) of 6.7 and no cytotoxicity to macrophage cells.
12 NA, protein, and promoter activity in murine macrophage cells.
13 evented LPS-mediated activation of Raw 264.7 macrophage cells.
14 owed for non-targeted, fluid-phase uptake by macrophage cells.
15 ent transcription from HIV-1 LTR in monocyte/macrophage cells.
16 mug/ml LPS exhibited no cytotoxic effects on macrophage cells.
17 mine the metabolic response of a 2D layer of macrophage cells.
18 e (LPS)-induced proinflammatory responses in macrophage cells.
19 ti-inflammatory activity on RAW 264.7 murine macrophage cells.
20 so demonstrated in the presence of RAW 264.7 macrophage cells.
21 osphate from small molecules present in host macrophage cells.
22 deacetylase-2 (HDAC2) in lung epithelial and macrophage cells.
23 iguing form of cell-to-cell transfer between macrophage cells.
24 mmatory cytokine production from human THP-1 macrophage cells.
25 ing activation of Kupffer cells and monocyte/macrophage cells.
26 tor 4 and STAT3-dependent mechanism in human macrophage cells.
27 onds of interaction of the bacteria with the macrophage cells.
28 ellular phospho-STAT3 levels in J774.2 mouse macrophage cells.
29 stimulate cAMP increases in RAW264.7 murine macrophage cells.
30 f ER- associated miRNPs observed in infected macrophage cells.
31 potted fever, able to activate dendritic and macrophage cells.
32 pared with release in noncancerous RAW 264.7 macrophage cells.
33 correlating with TNFalpha secretion in mouse macrophage cells.
34 assessed in LPS-stimulated RAW 264.7 murine macrophage cells.
35 g intracellular MRSA present inside infected macrophage cells.
36 ) in lipopolysaccharide-stimulated RAW 264.7 macrophage cells.
37 uces the cytotoxicity of the chelator in the macrophage cells.
39 the detection of nitric oxide released from macrophage cells and endothelial cells, demonstrating th
40 lization of perfluorocarbon nanoemulsions in macrophage cells and for measurements of mechanical forc
41 les (Ag-MBA@SiO(2)) were taken up by J774A.1 macrophage cells and measured a decrease in local pH dur
42 ging of HOCl fluctuations produced in living macrophage cells and peritonitis of living mice with hig
43 In this study, we show that in both RAW264.7 macrophage cells and primary bone marrow-derived macroph
44 rate that MVs can be delivered into cultured macrophage cells and subsequently stimulate a potent IFN
45 PHs display superior cell penetration within macrophage cells, and in some cases, minimal cytotoxicit
46 diatom-biosilica is non-cytotoxic to J774.2 macrophage cells, and supports cell proliferation and gr
47 translocate the effector protein VgrG-1 into macrophage cells, and T6SS activation leads to fecal dia
48 expression level of IL-1beta in LPS induced macrophage cells, and to cause significant reduction of
49 in glaucomatous eyes also indicate that ILM macrophage cells appear to play an early and regionally
50 ing LPS-induced proinflammatory responses in macrophage cells as well as in its interaction with LPS.
51 ble to inflict cellular damage in Caco-2 and macrophage cells, as assayed by LDH release, and escape
52 ld lower cytotoxicity toward RAW 264.7 mouse macrophage cells, as compared to the commercial transfec
53 -4 (IL-4) and IL-13 mediate their effects on macrophage cell biology, their biosynthesis, and respons
54 mulates C3 gene expression in human monocyte-macrophage cells but not in human hepatoma (HepG2) cells
56 tigotes when transformed into amastigotes in macrophage cells cannot be cured by treatment of macroph
57 atory responses in RAW 264.7 murine monocyte/macrophage cells challenged with the TLR4 agonist LPS an
60 relation to atherosclerosis, using as model macrophage cell cultures enriched with LDL particles.
61 ory cytokine and chemokine programs in mouse macrophage cell cultures, along with depression of innat
62 as been well studied, processes that control macrophage cell death and HMGB1 release in animals are p
63 were defective in Yop-mediated inhibition of macrophage cell death and ROS production in neutrophil-l
65 Mycobacterium tuberculosis modulation of macrophage cell death is a well-documented phenomenon, b
66 nt a unique mechanism of MSU crystal-induced macrophage cell death not rescued by pan-cathepsin inhib
67 triggers in induction of Cer production and macrophage cell death through elevated expression of A-F
68 etwork analysis predicted that VTRS1-induced macrophage cell death was mediated by a proinflammatory
70 TNF-alpha and IkappaB-alpha in VTRS1-induced macrophage cell death were further confirmed by individu
71 the role of A-FABP in promoting sFA-induced macrophage cell death with primary bone marrow-derived m
72 ent of the effects of IFN-beta on ST-induced macrophage cell death, but significantly dependent on IL
73 red for non-canonical inflammasome-triggered macrophage cell death, indicating that caspase-11 orches
74 r investigate the mechanism of VTRS1-induced macrophage cell death, microarrays were used to analyze
75 -8 and the RIP kinases are key regulators of macrophage cell death, NF-kappaB and inflammasome activa
84 stimulation, NR4A receptor-depleted monocyte/macrophage cells display significantly altered expressio
89 of microenvironmental signals that determine macrophage cell fate decisions to establish appropriate
95 ts showed that in B10.S, SJL/J, and RAW264.7 macrophage cells, IL-6 expression was dependent on extra
96 of THP stimulated the proliferation of human macrophage cells in culture and partially restored the n
98 re we examine key characteristics of retinal macrophage cells in live human eyes, both healthy and di
99 2 and IL-6) clustering with CD68(+) monocyte/macrophage cells in livers of subjects with dAIH, and is
100 was correlated with an increase in alveolar macrophage cells in the lungs and airways, early inducti
101 atory cytokines in RAW 264.7 and rat primary macrophage cells in the presence of LPS, MM-2 and Mel-SC
103 lpha in mouse bone marrow cells and monocyte/macrophage cells, in the absence of receptor activator o
104 ell metabolomic profiling using rat alveolar macrophage cells incubated with different concentrations
105 em to separate interaction stages and single macrophage cells infected with C. albicans from uninfect
106 that the inflammasome was not activated upon macrophage cell infection with murine gammaherpesvirus 6
107 fiber central nucleation and increased focal macrophage cell infiltration, indicating exacerbated dys
108 eoclasts derived from MAGP1Delta bone marrow macrophage cells is increased relative to the wild type,
109 from a dendritic cell line (JAWS II), from a macrophage cell line (C2.3), and from murine primary bon
110 thout affecting potassium efflux, in a mouse macrophage cell line (J774), mouse bone marrow-derived d
113 f cell migration response, particularly in a macrophage cell line (RAW/LR5) and only modestly in the
114 tivators as well as NFkappaB activation in a macrophage cell line (RAW264.7); however, DOPG was not i
115 d monocyte chemotactic protein-1 in a murine macrophage cell line and human primary macrophages.
116 by DNA affinity isolation from the RAW264.7 macrophage cell line and identified by mass spectrometry
117 tify genes overexpressed in the HD11 chicken macrophage cell line and in primary chicken oviduct epit
119 propose that exposure of macrophages (both a macrophage cell line and primary human alveolar macropha
120 nt debris both in vitro (using a human THP-1 macrophage cell line and primary human monocytes/macroph
121 induced IL-27 mRNA and protein levels in the macrophage cell line and primary lung monocytes/macropha
123 llular bacterial killing by a mouse alveolar macrophage cell line and primary mouse neutrophils.
127 hepatic macrophages (HMacs) and in a murine macrophage cell line by coupling transcriptional upregul
128 e responses to lipopolysaccharide in a human macrophage cell line cultured in 86 mM ethanol, 1 mM ace
129 ed with this aberrant translation in MEFs, a macrophage cell line depleted of CPEB and treated with l
133 modulate the immune response in the chicken macrophage cell line HD11 and in chicken primary monocyt
135 computed tomography imaging in the RAW 264.7 macrophage cell line identified the formulation that pro
139 ROS production was measured in the murine macrophage cell line J774 and in primary phagocytes usin
141 ns were toxic to mammalian cells, the murine macrophage cell line J774.16, in a LLO-dependent manner,
142 r knockdown of Aim2 expression in the murine macrophage cell line J774.A1, IFN-beta treatment of cell
146 from M-JAK2(-/-) mice and Jak2 knockdown in macrophage cell line RAW 264.7 also showed lower levels
147 We also observed MET formation by the mouse macrophage cell line RAW 264.7 and by human THP-1 cell-d
149 induced tolerant cells; knockdown of Neu1 in macrophage cell line RAW 264.7 cells resulted in enhance
150 In vitro, stable knockdown of HuR in mouse macrophage cell line RAW 264.7 corroborated in vivo data
153 se colon carcinoma cell line MC38, the mouse macrophage cell line RAW 264.7, or mouse and human organ
156 y, p66Shc was knocked down with siRNA in the macrophage cell line RAW264, and a 30% defect in superox
158 t on the inflammatory response of the murine macrophage cell line RAW264.7 and human monocyte THP-1 t
159 rmined that exosome production by the murine macrophage cell line RAW264.7 requires the endosomal sor
160 alveolar and peritoneal macrophages and the macrophage cell line RAW264.7, but not in primary bone m
161 hibition of dysferlin expression in the J774 macrophage cell line resulted in significantly enhanced
162 Overexpression of gga-miR-429 in the HD11 macrophage cell line significantly inhibited TMEFF2 and
163 Similar results were obtained in a murine macrophage cell line stimulated with the TLR7 agonist co
164 (B6.Nba2-ABC) splenic cells and in a murine macrophage cell line that overexpressed p202 protein was
168 derived from CD44-deficient mice, in an MH-S macrophage cell line treated with antibodies to CD44, or
171 man monocyte-derived macrophages and a mouse macrophage cell line were used to determine effects of c
173 34Delta cells after phagocytosis by a murine macrophage cell line, and Atg8 expression was exhibited
174 J2-C8 cell line (AM cells), a mouse alveolar macrophage cell line, and ESK-1 cells, a mouse gingival
175 restingly, sCD16 inhibited MDALDL binding to macrophage cell line, as well as soluble forms of recomb
176 genesis of RAW264.7 cells, a murine monocyte/macrophage cell line, by suppressing the induction of NF
178 of SCN8A from THP-1 cells, a human monocyte-macrophage cell line, confirmed the expression of a full
179 of IL-12p40 was investigated using a murine macrophage cell line, CRL2019, in an in vitro MW model.
180 Ocm), a Ca(2+)-binding protein secreted by a macrophage cell line, is a potent axon-promoting factor
182 e showed that in primary keratinocytes and a macrophage cell line, PG suppressed inflammatory mediato
183 Similarly, treatment of human PBMCs or mouse macrophage cell line, RAW 264.4, with TGF-beta, induced
205 oxygenase, no cytotoxicity against RAW 264.7 macrophage cells line, and a weak potential to decrease
206 targeting of FXIII-A in the THP-1 (monocyte/macrophage) cell line and in human monocyte-derived macr
208 Endothelial cells (cell line: TIME) and macrophages (cell line: RAW264.7) were treated with vari
210 o be upregulated in M. leprae-infected human macrophage cell lineages, primary monocytes, and skin le
212 ages (C57BL/6, BALB/c, and p47(phox-/-)) and macrophage cell lines (RAW 264.7 and IC21) to investigat
213 ndirectly promoted the uptake of bacteria by macrophage cell lines and directly killed bacteria at ac
216 ver, the mutant shows impaired growth within macrophage cell lines and is severely attenuated in zebr
217 er into both folate receptor beta-expressing macrophage cell lines and primary mouse macrophages.
218 for survival/growth within human and murine macrophage cell lines and was unable to escape from phag
220 ated in a time- and dose-dependent manner in macrophage cell lines derived from AFABP/aP2-EFABP/mal1
225 e we show, with global proteomic analysis of macrophage cell lines treated with either IFNgamma or IL
226 fect different primary cells and established macrophage cell lines with deletions in the Toll-like re
227 ilitate such virulence screens, we developed macrophage cell lines with which the number of intact ho
228 thogen to inhibit the phagocytic activity of macrophage cell lines, an event that can be correlated w
230 ing to stably knock out and recover Rab8a in macrophage cell lines, we match Akt signaling profiles w
231 human mammary epithelial cells and monocyte/macrophage cell lines, we show that the chromatin bounda
241 ngs, CCR7 gene expression in human and mouse macrophages cell lines is induced when LXRalpha at S198
246 esulted in significant reduction in monocyte/macrophage cell numbers within PBMCs in a dose-dependent
248 g vertebrates, was downregulated in RAW264.7 macrophage cells of the M2 phenotype in conditoned mediu
251 21R system should consider that monocyte and macrophage cell physiology may be affected by this syste
252 ed increased levels of DPP4 expression in DC/macrophage cell populations from visceral adipose tissue
259 siRNA or functional TR4 cDNA in the RAW264.7 macrophage cells resulted in either decreased or increas
260 ng functional CD36 cDNA in the TR4 knockdown macrophage cells reversed the decreased foam cell format
262 Using a micropatterning approach to control macrophage cell shape directly, we demonstrate here that
264 eritoneal macrophages, we confirm a role for macrophage cell surface beta3 integrin in this dl922-947
269 s approach by imaging human monocyte-derived macrophage cells that have been exposed to fibrils from
270 we hypothesize that the removal of the liver macrophages, cells that have been reported to take up th
271 based on the study of blood monocyte-derived macrophages, cells that have never been exposed to the w
275 asma virulence, we employed these transgenic macrophage cells to screen a collection of individual tr
277 gas phase and fluorescence imaging of NO2 in macrophage cells treated with a nitrogen dioxide donor.
278 crease in the optical force was also seen in macrophage cells treated with cytochalasin D, both with
279 xpressed JunB is cleaved in murine RAW 264.7 macrophage cells treated with the NALP1b inflammasome ac
280 the stress pathways activated, depending on macrophage cell type, consistent with the nonspecific na
281 onfirmed in vivo in mice with hepatocyte and macrophage cell-type-specific conditional Ron deletions.
285 in the optical force experienced by RAW264.7 macrophage cells upon the uptake of both microparticles
286 ied particles remained resistant to cultured macrophage cell uptake, although they were still quickly
287 The infiltration of polymorphonuclear and macrophage cells was associated with increased ocular me
289 e viability and ATP levels in epithelial and macrophage cells, we discovered for fumed silica an impo
291 of the first indicators of oxidative burst, macrophage cells were exposed within the microfluidic de
293 ession analysis of bacteria infecting murine macrophage cells were performed under four distinct cond
296 e latter case by taking PSFC measurements of macrophage cells when inoculated with enhanced green flu
297 sc1), is required for fungal survival inside macrophage cells, which is consistent with the role of F
300 retinal microglia, the ability to visualize macrophage cells without fluorescent labeling in the liv